Back to home Technology & development

India Extends Medical Device PLI Scheme, Removes Sales Thresholds

Tholth News Desk ·
India Extends Medical Device PLI Scheme, Removes Sales Thresholds

The Indian government has reopened applications for its Production Linked Incentive (PLI) scheme dedicated to medical devices and extended the program’s tenure until the 2035-36 fiscal year. The Department of Pharmaceuticals, operating under the Ministry of Chemicals and Fertilizers, announced the changes on Tuesday.

To encourage participation, officials simplified scheme guidelines and lowered barriers for manufacturers. The revised rules eliminate the minimum sales threshold previously required to claim financial incentives. Additionally, the government reduced the baseline capital expenditure requirements for companies seeking to qualify.

Program Revisions and Eligibility

The PLI scheme, originally launched in 2020-21, aims to promote domestic manufacturing. According to the department, the program has facilitated the local production of over 60 high-end medical devices and components, generating production value exceeding Rs 16,000 crore. These items include CT scanners, 1.5T MRI machines, mammography equipment, and various implants.

Under the new guidelines, applicants have three years to establish manufacturing facilities across four specific segments:

  • Medical consumables, disposables, and implants.
  • Critical components.
  • High-end medical devices currently at a nascent stage of domestic production.
  • High-end medical devices currently only assembled within the country.

The government will open an online portal for new applications within 10 days. By focusing on critical components, the initiative seeks to integrate supply chains and support the MSME sector.

Strategic Objectives

The initiative, titled PLI-MD 2.0, is designed to support the “Atmanirbhar Bharat” (Self-Reliant India) and “Make in India” policies. The stated goals include reducing device prices, generating employment, and enhancing global competitiveness. The government also intends to incentivize the production of complex equipment not yet manufactured domestically, such as 3T MRI machines, PET-CT scanners, and high-throughput IVD analysers.

← Previous Lancia Gamma to Feature in Italian Elegance Tour Next → Tech Leaders Weigh Risks of AI-Driven Software Development